• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - 코스닥
Tag:

코스닥

Health

KODEX 200 Inverse 2X Plummets 58%: Funeral Ads Appear on Investor Forums

by Chief Editor February 25, 2026
written by Chief Editor

The Rise and Fall of Leveraged ETFs: A Cautionary Tale for Investors

The recent surge in the Korean stock market, with the KOSPI exceeding 6000 points, has brought renewed attention – and pain – to investors in leveraged ETFs, particularly the KODEX 200 Futures Inverse 2X ETF (ticker: 252670). Online communities dedicated to these high-risk investments are now seeing a surprising influx of advertisements for funeral services and debt restructuring, highlighting the financial distress experienced by some investors.

What are Leveraged Inverse ETFs?

Leveraged inverse ETFs, often called “곱버스” (gopbeoseu) in Korea, are designed to deliver the inverse of the daily performance of an underlying index, multiplied by a specific leverage factor. In the case of the KODEX 200 Futures Inverse 2X ETF, it aims to provide -2x the daily return of the KOSPI 200 futures index. This means if the KOSPI 200 futures fall by 1% in a day, the ETF *should* rise by 2%. Conversely, a 1% rise in the index results in a 2% loss for the ETF.

According to Samsung Asset Management, the fund’s expense ratio is 0.64% annually, a relatively low cost compared to similar leveraged ETFs in the US.

The Risks of Leverage and the “Compounding Effect”

While potentially lucrative in short-term market downturns, leveraged ETFs are not designed for long-term holding. The daily rebalancing inherent in their structure leads to a phenomenon known as “volatility drag” or the “compounding effect.” This means that over longer periods, the ETF’s returns can deviate significantly from the simple inverse multiple of the underlying index’s performance. The longer the holding period, and the more volatile the market, the greater the potential for unexpected and substantial losses.

Recent Performance and Investor Behavior

As of February 25, 2026, the KODEX 200 Futures Inverse 2X ETF has experienced a year-to-date loss of 58.05% as the KOSPI has continued its upward trajectory. Despite the inherent risks, data from the Korea Exchange shows that individual investors have collectively purchased 993 billion Korean won worth of the ETF so far this year. This suggests a continued, and potentially misguided, belief in a market correction.

Why the Funeral Home Ads?

The appearance of advertisements for funeral services and personal bankruptcy assistance within online communities dedicated to this ETF is a stark illustration of the financial consequences faced by some investors. The combination of leverage and a sustained bull market has proven devastating for those betting against the market. Online commentary reflects a sense of despair, with users making grim jokes about the require for end-of-life planning.

Understanding the Underlying Index

It’s crucial to understand that the KODEX 200 Futures Inverse 2X ETF tracks the F-KOSPI200 futures index, not the KOSPI 200 itself. This distinction is often misunderstood by investors, leading to frustration when the ETF doesn’t perfectly mirror the movements of the broader index.

Frequently Asked Questions (FAQ)

Q: Are leveraged ETFs suitable for all investors?
A: No. They are high-risk products best suited for sophisticated investors with a short-term trading horizon and a thorough understanding of the risks involved.

Q: What is the “compounding effect”?
A: The daily rebalancing of leveraged ETFs can lead to returns that differ significantly from the simple inverse multiple of the underlying index’s performance, especially over longer periods.

Q: What is the expense ratio of the KODEX 200 Futures Inverse 2X ETF?
A: The expense ratio is 0.64% annually.

Q: Does this ETF pay dividends?
A: No, it does not pay dividends.

Q: What should investors do if they are experiencing losses?
A: Investors should carefully review their investment strategy, consider seeking financial advice, and understand the potential for further losses.

Pro Tip: Before investing in any leveraged ETF, carefully read the prospectus and understand the risks involved. Don’t invest more than you can afford to lose.

Did you grasp? The KODEX 200 Futures Inverse 2X ETF is one of the most actively traded ETFs in Korea.

Explore other ETF options and investment strategies to diversify your portfolio and manage risk. Consider consulting with a financial advisor to determine the best investment approach for your individual circumstances.

February 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Tech

South Korean AI Firm Handalab Lists on Nasdaq with Automation Technology

by Chief Editor February 2, 2026
written by Chief Editor

South Korean Tech Innovation: From Lab to Nasdaq and Beyond

A quiet revolution is underway in South Korea’s tech sector, fueled by government support for research and development (R&D) and a growing number of successful spin-off companies. The recent Nasdaq entry of Handalab, an AI-powered smart factory specialist originating from the Daedeok R&D Special Zone, marks a significant milestone – and a potential blueprint for future growth. This isn’t just a win for Handalab; it signals a broader trend of deep-tech commercialization gaining momentum.

The Rise of the R&D Special Zones

For years, South Korea has strategically invested in specialized R&D zones like Daedeok Innopolis, aiming to bridge the gap between academic research and market application. The Ministry of Science and ICT (MSIT) is now seeing tangible results. Handalab’s success, built on programs like the ‘Technology Discovery and Connection Support Program’ and the ‘Research Institute Spin-off Company Competency Enhancement Program (R&BD),’ demonstrates the effectiveness of this stage-by-stage support system. The 2026 investment of 167.3 billion KRW – a 44% increase from the previous year – underscores the government’s commitment to expanding these initiatives.

This isn’t an isolated case. Companies like Alteogen, Rainbow Robotics, LigaChem Bio, and Peptron, all boasting significant market capitalization on the KOSDAQ, also trace their roots back to these R&D zones. Furthermore, Cureverse and Sovargen’s substantial technology transfer deals (500 billion KRW and 750 billion KRW respectively) with global pharmaceutical giants highlight the quality of innovation emerging from these hubs.

Nasdaq as the New Frontier

Traditionally, Korean research spin-offs have focused on listing on the KOSDAQ exchange. Handalab’s decision to pursue a Nasdaq listing is a game-changer. It signifies a desire for greater access to capital, a larger investor base, and increased global visibility. This move could encourage other deep-tech companies to consider the U.S. market earlier in their growth trajectory.

Did you know? The Nasdaq is increasingly becoming a destination for international tech companies seeking access to U.S. capital markets. In 2023, over 20% of Nasdaq listings were from companies outside the United States, according to Nasdaq’s own data. Nasdaq Global Equity Listings

Beyond Manufacturing: Medical Devices and AI

The impact extends beyond the smart factory sector. Endorobotics, the first Korean medical device company to receive an FDA NAY code (for robot-assisted surgical systems), and Intocell, which utilized the technology special listing track on the KOSDAQ, are further examples of successful commercialization driven by government support. This diversification demonstrates the broad applicability of the R&D Special Zone model.

The common thread linking these successes is the application of advanced technologies – particularly artificial intelligence. Handalab’s AI-automated production process, for example, is directly applicable to the strategic metals supply chain through its partnership with EMAT. This integration of AI isn’t merely about automation; it’s about creating more resilient, efficient, and innovative supply chains.

Future Trends: What to Expect

Several key trends are likely to shape the future of this ecosystem:

  • Increased Focus on Deep Tech: Expect more investment in areas like biotechnology, advanced materials, and quantum computing.
  • Global Partnerships: Collaboration with international companies, like Handalab’s partnership with EMAT, will become increasingly common.
  • Expansion of R&D Zones: The success of Daedeok Innopolis may lead to the creation of new specialized R&D zones focused on specific industries.
  • Streamlined Regulatory Processes: The government will likely continue to refine regulations to facilitate the commercialization of research findings.
  • Talent Acquisition and Retention: Attracting and retaining skilled researchers and engineers will be crucial for sustained growth.

Pro Tip: For companies looking to leverage South Korea’s R&D ecosystem, understanding the specific support programs offered by the MSIT and the R&D Special Zones is essential. Ministry of Science and ICT (MSIT)

FAQ

Q: What is the Daedeok R&D Special Zone?
A: It’s a designated area in South Korea focused on fostering research and development and commercializing technological innovations.

Q: What is a research institute spin-off company?
A: A company created to commercialize technology developed within a research institute or university.

Q: What is an NAY code?
A: A medical device classification code assigned by the U.S. Food and Drug Administration (FDA) to robot-assisted surgical systems.

Q: What role does the MSIT play?
A: The Ministry of Science and ICT provides funding, support programs, and regulatory guidance to promote R&D and commercialization.

Q: What is the significance of a Nasdaq listing?
A: It provides access to a larger investor base, increased global visibility, and potentially higher valuations.

The success of Handalab and its peers isn’t just a story about technological innovation; it’s a testament to the power of strategic government investment and a commitment to fostering a vibrant ecosystem for deep-tech commercialization. As South Korea continues to refine its approach, it’s poised to become a global leader in the next wave of technological breakthroughs.

Reader Question: What other sectors do you see benefiting from this R&D push?

Explore More: Read our article on The Future of Smart Factories and South Korea’s AI Strategy.

Stay Informed: Subscribe to our newsletter for the latest insights on technology and innovation!

February 2, 2026 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Fuel stocks fall again, one shipment delayed but ‘no risk’ says PM

    April 15, 2026
  • Patient tells Ontario inquest Heather Winterstein was on floor ‘crying in pain’ in hospital ER on day she died

    April 15, 2026
  • DRAGON QUEST SMASH/GROW , THE NEWEST ADDITION TO THE DRAGON QUEST SERIES, OFFICIALLY LAUNCHES APRIL 20

    April 15, 2026
  • Westzaan Prison: Bomb Threat & EOD Investigation – Update

    April 15, 2026
  • Support of trusted regional partners key to securing energy needs: PM Wong

    April 15, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World